期刊文献+

表观遗传学及现代表观遗传生物医药技术的发展 被引量:9

The Developments of Epigenetics and Epigenetics-based Modern Biomedicine and Pharmaceutics
下载PDF
导出
摘要 表观遗传学和基于表观遗传机制的生物医药技术的研究已经成为后基因组时代生命科学技术领域的重要组成部分。围绕肿瘤、心脑血管疾病、糖尿病及中老年神经退行性疾病等过程中DNA甲基化修饰、组蛋白翻译后修饰及非编码RNA等表观遗传学改变的深入研究,不仅有利于理解相关疾病的分子病理机制,而且,更有助于探寻基于表观遗传机制的有效治疗手段。在阐释表观遗传学修饰机制的基础上,对疾病过程中异常的表观遗传学修饰及相关生物医药技术的研究现状进行了归纳总结。 Epigenetics and epigenetic mechanism-based biomedical technologies have emerged as important research fields in post-genomic area. In-depth investigation on epigenetic alterations of DNA methylation, histone modifications, non-coding RNAs, etc. in tumorigenesis, cardiovascular disease, diabetes, and neurodegenerative diseases associated with the elderly population is not only beneficial to the understanding of the molecular pathogenesis of the diseases, but also useful in exploring effective treatments based upon epigenetic mechanisms. This review first briefly introduces epigenetic modification mechanisms, then summarizes current research progress on abnormal epigenetic modifications in the disease conditions, and also discusses the relevant biomedical technology.
作者 姜楠 潘学峰
出处 《生物技术通报》 CAS CSCD 北大核心 2015年第4期105-119,共15页 Biotechnology Bulletin
基金 北京市自然科学基金项目(5132014) 北京理工大学自然科学基础基金项目(3160012211215)
关键词 表观遗传学 DNA甲基化 组蛋白翻译后修饰 非编码RNA 人类疾病 epigenetics DNA methylation histone post-translational modification non-coding RNA human diseases
  • 相关文献

参考文献4

二级参考文献467

  • 1Mirkin SM. Expandable DNA repeats and human disease. Nature, 2007, 44: 932-940.
  • 2Mirkin SM. DNA structures, repeat expansions and human hereditar) disorders. Curr Opin Neurobiol, 2006, 16: 351-358.
  • 3Bacolla A, Wells RD. Non-B DNA Conformations, genomic rearrangements, and human disease. J Biolehem, 2004, 279 : 47411- 47414.
  • 4Everett CM, Wood NW. Trinucleotide repeats in neurodegenerative disease. Brain, 2004, 1279: 2385-2405.
  • 5Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: Mechansims of dynamic mutations. Nat Rev Genet, 2005, 6: 729-742.
  • 6McMunay CT. DNA secondary structure : A common and causative factor for expansion in human disease. Proc Natl Acad Sci U S A, 1999, 96: 1823-1825.
  • 7Montermini L, Richter A, Morgan K, et al. Phenotypic variability in Friedreich ataxia : Role of the associated GAA triplet repeat expansion. Ann Neurol, 1997, 41 : 675-582.
  • 8Durr A, Cossee M, Agid Y, et al. Clinical and genetle abnormalities in patients with Friedreich's ataxia. N Engl J Med, 1996, 335: 1169-1175.
  • 9Geoffroy G, Barbeau A, Breton G, et al. Clinical description and rnentgenologic evaluation of patients with Friedreich ataxia. Can J Neurol Scl, 1976, 3: 279-286.
  • 10Chamberlain S, Shaw J, Rowland A, et al. Mapping of mutation causing Friedreich ataxia to human chromosome 9. Nature, 1988, 334: 248-250.

共引文献56

同被引文献49

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部